Literature DB >> 21737695

Beyond ipilimumab: new approaches target the immunological synapse.

Ken Garber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737695     DOI: 10.1093/jnci/djr281

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Authors:  Matthias T Stephan; Sirkka B Stephan; Peter Bak; Jianzhu Chen; Darrell J Irvine
Journal:  Biomaterials       Date:  2012-05-15       Impact factor: 12.479

Review 2.  Fine-tuning of dendritic cell biology by the TNF superfamily.

Authors:  Leslie Summers deLuca; Jennifer L Gommerman
Journal:  Nat Rev Immunol       Date:  2012-04-10       Impact factor: 53.106

Review 3.  Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Authors:  Leisha A Emens
Journal:  Expert Rev Anticancer Ther       Date:  2012-12       Impact factor: 4.512

Review 4.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Authors:  Danny N Khalil; Eric L Smith; Renier J Brentjens; Jedd D Wolchok
Journal:  Nat Rev Clin Oncol       Date:  2016-03-15       Impact factor: 66.675

5.  The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells.

Authors:  Gunter Rappl; Tobias Riet; Sabine Awerkiew; Annette Schmidt; Andreas A Hombach; Herbert Pfister; Hinrich Abken
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 6.  Targeting costimulatory molecules to improve antitumor immunity.

Authors:  Daria Capece; Daniela Verzella; Mariafausta Fischietti; Francesca Zazzeroni; Edoardo Alesse
Journal:  J Biomed Biotechnol       Date:  2012-02-12

7.  What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?

Authors:  Oliver G Donnelly; Alan A Melcher; Richard G Vile; Jose Pulido
Journal:  Immunotherapy       Date:  2012-08       Impact factor: 4.196

Review 8.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07

Review 9.  Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape.

Authors:  Neeharika Srivastava; David McDermott
Journal:  Cancer Manag Res       Date:  2014-06-20       Impact factor: 3.989

10.  Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells.

Authors:  Anita Kumari; Ercan Cacan; Susanna F Greer; Charlie Garnett-Benson
Journal:  J Immunother Cancer       Date:  2013-09-23       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.